• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疟原虫嘌呤核苷磷酸化酶的新型二肽抑制剂:基于计算机模拟筛选有前景的新型抗疟药

Novel Dipeptide Inhibitors of PfPNP: In-Silico Identification of Promising New Antimalarials.

作者信息

Devi Kanika, Chandra Anshuman, Chaudhuri Susmita, Kumar Goel Vijay

机构信息

School of Physical Sciences, Jawaharlal Nehru University, New Delhi, 110067, India.

Centre for Biodesign, Translational Health Science and Technology Institute, Faridabad, Haryana, 121001, India.

出版信息

Chem Biodivers. 2025 Jan;22(1):e202401668. doi: 10.1002/cbdv.202401668. Epub 2024 Nov 9.

DOI:10.1002/cbdv.202401668
PMID:39345161
Abstract

Malaria, an infectious disease caused by Plasmodium falciparum, is becoming increasingly difficult to treat due to the emergence of drug-resistant strains. Recent studies have proposed purine nucleoside phosphorylase from P. falciparum (PfPNP) as a potential target for malaria treatment. In the present study, we designed a virtual library of 400 dipeptides to discover novel anti-malarial peptide inhibitors. A structure-based molecular docking method was employed to virtually screen the designed library against the wild-type structure of PfPNP (PDB: 5ZNC). The best four (Phe-Arg, Arg-His, Trp-Arg and Tyr-Arg) dipeptides, which were then investigated for their binding potential against PfPNP using Molecular Dynamics simulation studies. Parameters such as RMSD, RMSF, Rg, and SASA were analyzed to understand the structural changes, energetics, and overall behavior of PfPNP-dipeptide complexes. The PfPNP demonstrated significant stability upon binding with each of the identified dipeptides with ΔG of over -168 kcal/mol. Additionally, DFT and ADME predictions indicated that the electronic structure, energetics, and pharmacokinetic properties of Phe-Arg, Arg-His, Trp-Arg and Tyr-Arg were favourable for drug development. Our comprehensive computational investigation has identified these four dipeptides as promising candidates. These designed and selected dipeptides may further be modified using peptidomimetic and medicinal chemistry tools to develop a novel class of promising antimalarials.

摘要

疟疾是一种由恶性疟原虫引起的传染病,由于耐药菌株的出现,其治疗难度越来越大。最近的研究提出,恶性疟原虫的嘌呤核苷磷酸化酶(PfPNP)作为疟疾治疗的潜在靶点。在本研究中,我们设计了一个包含400种二肽的虚拟文库,以发现新型抗疟肽抑制剂。采用基于结构的分子对接方法,针对PfPNP的野生型结构(PDB:5ZNC)对设计的文库进行虚拟筛选。然后使用分子动力学模拟研究对最佳的四种二肽(苯丙氨酸-精氨酸、精氨酸-组氨酸、色氨酸-精氨酸和酪氨酸-精氨酸)与PfPNP的结合潜力进行研究。分析了均方根偏差(RMSD)、均方根波动(RMSF)、回旋半径(Rg)和溶剂可及表面积(SASA)等参数,以了解PfPNP-二肽复合物的结构变化、能量学和整体行为。PfPNP与每种鉴定出的二肽结合时表现出显著的稳定性,自由能变化(ΔG)超过-168 kcal/mol。此外,密度泛函理论(DFT)和药物代谢动力学(ADME)预测表明,苯丙氨酸-精氨酸、精氨酸-组氨酸、色氨酸-精氨酸和酪氨酸-精氨酸的电子结构、能量学和药代动力学性质有利于药物开发。我们全面的计算研究已将这四种二肽确定为有前景的候选物。这些设计和选择的二肽可进一步使用拟肽和药物化学工具进行修饰,以开发一类新型的有前景的抗疟药物。

相似文献

1
Novel Dipeptide Inhibitors of PfPNP: In-Silico Identification of Promising New Antimalarials.疟原虫嘌呤核苷磷酸化酶的新型二肽抑制剂:基于计算机模拟筛选有前景的新型抗疟药
Chem Biodivers. 2025 Jan;22(1):e202401668. doi: 10.1002/cbdv.202401668. Epub 2024 Nov 9.
2
Identification of a novel putative inhibitor of the Plasmodium falciparum purine nucleoside phosphorylase: exploring the purine salvage pathway to design new antimalarial drugs.鉴定新型疟原虫嘌呤核苷磷酸化酶的假定抑制剂:探索嘌呤补救途径以设计新型抗疟药物。
Mol Divers. 2017 Aug;21(3):677-695. doi: 10.1007/s11030-017-9745-8. Epub 2017 May 18.
3
Identification of a peptide derived from a Bothrops moojeni metalloprotease with in vitro inhibitory action on the Plasmodium falciparum purine nucleoside phosphorylase enzyme (PfPNP).从莫氏矛头蝮金属蛋白酶衍生的肽的鉴定,该肽在体外对恶性疟原虫嘌呤核苷磷酸化酶酶(PfPNP)具有抑制作用。
Biochimie. 2019 Jul;162:97-106. doi: 10.1016/j.biochi.2019.04.009. Epub 2019 Apr 9.
4
Plasmodium falciparum purine nucleoside phosphorylase as a model in the search for new inhibitors by high throughput screening.恶性疟原虫嘌呤核苷磷酸化酶作为高通量筛选寻找新抑制剂的模型。
Int J Biol Macromol. 2020 Dec 15;165(Pt B):1832-1841. doi: 10.1016/j.ijbiomac.2020.10.062. Epub 2020 Oct 16.
5
Plasmodium falciparum purine nucleoside phosphorylase: crystal structures, immucillin inhibitors, and dual catalytic function.恶性疟原虫嘌呤核苷磷酸化酶:晶体结构、免疫菌素抑制剂及双重催化功能
J Biol Chem. 2004 Apr 30;279(18):18103-6. doi: 10.1074/jbc.C400068200. Epub 2004 Feb 23.
6
Genetic resistance to purine nucleoside phosphorylase inhibition in .嘌呤核苷磷酸化酶抑制的遗传耐药性。
Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):2114-2119. doi: 10.1073/pnas.1525670115. Epub 2018 Feb 12.
7
A resistant mutant of Plasmodium falciparum purine nucleoside phosphorylase uses wild-type neighbors to maintain parasite survival.恶性疟原虫嘌呤核苷磷酸化酶的耐药突变株利用野生型相邻酶维持寄生虫存活。
J Biol Chem. 2021 Jan-Jun;296:100342. doi: 10.1016/j.jbc.2021.100342. Epub 2021 Jan 30.
8
Plasmodium falciparum purine nucleoside phosphorylase is critical for viability of malaria parasites.恶性疟原虫嘌呤核苷磷酸化酶对疟原虫的生存至关重要。
J Biol Chem. 2008 Dec 19;283(51):35899-907. doi: 10.1074/jbc.M807218200. Epub 2008 Oct 28.
9
Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).采用高通量虚拟筛选、对接和分子动力学模拟的多电子药效团模型,发现潜在的恶性疟原虫乳酸脱氢酶(PfLDH)抑制剂。
J Biomol Struct Dyn. 2019 Apr;37(7):1783-1799. doi: 10.1080/07391102.2018.1471417. Epub 2018 May 14.
10
Identification and structural validation of purine nucleoside phosphorylase from Plasmodium falciparum as a target of MMV000848.鉴定和结构验证恶性疟原虫中的嘌呤核苷磷酸化酶作为 MMV000848 的靶标。
J Biol Chem. 2024 Jan;300(1):105586. doi: 10.1016/j.jbc.2023.105586. Epub 2023 Dec 21.

引用本文的文献

1
Spatial regulation of chrysosplenetin on amino acid homeostasis linked to artemisinin resistance in Plasmodium berghei K173 based on targeted metabolomics.基于靶向代谢组学研究金腰乙素对伯氏疟原虫K173青蒿素抗性相关氨基酸稳态的空间调控作用
Sci Rep. 2025 Apr 21;15(1):13701. doi: 10.1038/s41598-025-98409-x.